KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Adaptive Biotechnologies (ADPT) Receivables - Other (2018 - 2025)

Adaptive Biotechnologies' Receivables - Other history spans 8 years, with the latest figure at $1.5 million for Q4 2025.

  • For Q4 2025, Receivables - Other rose 15.38% year-over-year to $1.5 million; the TTM value through Dec 2025 reached $1.5 million, up 15.38%, while the annual FY2025 figure was $1.5 million, 15.38% up from the prior year.
  • Receivables - Other for Q4 2025 was $1.5 million at Adaptive Biotechnologies, roughly flat from $1.5 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $2.8 million in Q1 2021 and bottomed at $800000.0 in Q2 2022.
  • The 5-year median for Receivables - Other is $1.2 million (2024), against an average of $1.3 million.
  • The largest annual shift saw Receivables - Other soared 55.56% in 2021 before it plummeted 65.22% in 2022.
  • A 5-year view of Receivables - Other shows it stood at $1.4 million in 2021, then crashed by 42.86% to $800000.0 in 2022, then increased by 25.0% to $1.0 million in 2023, then grew by 30.0% to $1.3 million in 2024, then increased by 15.38% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Receivables - Other are $1.5 million (Q4 2025), $1.5 million (Q3 2025), and $1.3 million (Q2 2025).